PHARMAESSENTIA monthly revenue
PHARMAESSENTIA CORP
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$2.3B | -5.1% | +94.9% | NT$12B |
| May 2026 | Jun 17, 2026 | NT$2.5B | +19.1% | +108.5% | NT$9.6B |
| Apr 2026 | May 17, 2026 | NT$2.1B | +6.4% | +68.3% | NT$7.2B |
| Mar 2026 | Apr 17, 2026 | NT$1.9B | +21.2% | +64.4% | NT$5.1B |
| Feb 2026 | Mar 17, 2026 | NT$1.6B | +1.2% | +56.7% | NT$3.2B |
| Jan 2026 | — | NT$1.6B | — | +49.8% | NT$1.6B |
| Dec 2025 | — | NT$1.9B | — | +69.9% | NT$15.6B |
| Nov 2025 | — | NT$1.6B | — | +53.0% | NT$13.7B |
| Oct 2025 | — | NT$1.4B | — | +53.6% | NT$12.2B |
| Sep 2025 | — | NT$1.3B | — | +41.3% | NT$10.8B |
| Aug 2025 | — | NT$1.3B | — | +41.4% | NT$9.4B |
| Jul 2025 | — | NT$1.3B | — | +48.0% | NT$8.2B |
| Jun 2025 | — | NT$1.2B | — | +41.1% | NT$6.9B |
| May 2025 | — | NT$1.2B | — | +49.1% | NT$5.7B |
| Apr 2025 | — | NT$1.2B | — | +83.7% | NT$4.5B |
| Mar 2025 | — | NT$1.2B | — | +111.5% | NT$3.3B |
| Feb 2025 | — | NT$1B | — | +73.8% | NT$2.1B |
| Jan 2025 | — | NT$1.1B | — | +107.9% | NT$1.1B |
| Dec 2024 | — | NT$1.2B | — | +73.9% | NT$9.8B |
| Nov 2024 | — | NT$1B | — | +138.9% | NT$8.6B |
| Oct 2024 | — | NT$0.9B | — | +67.0% | NT$7.6B |
| Sep 2024 | — | NT$0.9B | — | +132.1% | NT$6.7B |
| Aug 2024 | — | NT$0.9B | — | +96.5% | NT$5.7B |
| Jul 2024 | — | NT$0.9B | — | +97.3% | NT$4.8B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-09. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.